Press Releases

30.05.2022

Prof. Dr Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons

Corporate

Show Article

04.04.2022

Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

Technology

Show Article

09.03.2022

Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG

Corporate Finance

Show Article

23.02.2022

BRAIN Biotech AG: Very Dynamic Start into the Fiscal Year 2021/22, 3M Reporting

Finance

Show Article

02.02.2022

AnalytiCon Discovery and Pharvaris extend their collaboration

Corporate Technology

Show Article

01.02.2022

BRAIN Group significantly expands its food enzyme business with the acquisition of Breatec B.V. and Comix business

Corporate

Show Article

17.01.2022

BRAIN Biotech AG publishes Annual Report for FY 2020/21

Finance Corporate

Show Article

11.01.2022

BRAIN-Engineered-Cas (BEC) Considered a Patentable Technology

Technology Corporate

Show Article

08.12.2021

Additional Genome Editing Nuclease: BRAIN-Metagenome-Cas 01 (BMC01)

Technology

Show Article